283 related articles for article (PubMed ID: 31299389)
21. Sustained ERK [corrected] inhibition by EGFR targeting therapies is a predictive factor for synergistic cytotoxicity with PDT as neoadjuvant therapy.
Weyergang A; Selbo PK; Berg K
Biochim Biophys Acta; 2013 Mar; 1830(3):2659-70. PubMed ID: 23671927
[TBL] [Abstract][Full Text] [Related]
22. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
[TBL] [Abstract][Full Text] [Related]
23. Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice.
Inoue K; Torimura T; Nakamura T; Iwamoto H; Masuda H; Abe M; Hashimoto O; Koga H; Ueno T; Yano H; Sata M
Clin Cancer Res; 2012 Jul; 18(14):3924-33. PubMed ID: 22611027
[TBL] [Abstract][Full Text] [Related]
24. Triple-negative breast cancer treatment in xenograft models by bifunctional nanoprobes combined to photodynamic therapy.
Dos Santos Jesus VP; Vieira PFA; Cintra RC; Sant'Anna LB; Zezell DM; Castilho ML; Raniero L
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102796. PubMed ID: 35263669
[TBL] [Abstract][Full Text] [Related]
25. A novel chlorin e6 derivative-mediated photodynamic therapy STBF-PDT reverses photoaging via the TGF-β pathway.
Shi J; Zeng Q; Wang P; Chang Q; Huang J; Wu M; Wang X; Wang H
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103321. PubMed ID: 36738905
[TBL] [Abstract][Full Text] [Related]
26. Modulation of EGFR and ROS induced cytochrome c release by combination of photodynamic therapy and carboplatin in human cultured head and neck cancer cells and tumor xenograft in nude mice.
Hwang H; Biswas R; Chung PS; Ahn JC
J Photochem Photobiol B; 2013 Nov; 128():70-7. PubMed ID: 24035846
[TBL] [Abstract][Full Text] [Related]
27. EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.
van Driel PBAA; Boonstra MC; Slooter MD; Heukers R; Stammes MA; Snoeks TJA; de Bruijn HS; van Diest PJ; Vahrmeijer AL; van Bergen En Henegouwen PMP; van de Velde CJH; Löwik CWGM; Robinson DJ; Oliveira S
J Control Release; 2016 May; 229():93-105. PubMed ID: 26988602
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia alleviating platinum(IV)/chlorin e6-based combination chemotherapeutic-photodynamic nanomedicine for oropharyngeal carcinoma.
Paul M; Itoo AM; Ghosh B; Biswas S
J Photochem Photobiol B; 2023 Jan; 238():112627. PubMed ID: 36525775
[TBL] [Abstract][Full Text] [Related]
29. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer.
Edmonds C; Hagan S; Gallagher-Colombo SM; Busch TM; Cengel KA
Cancer Biol Ther; 2012 Dec; 13(14):1463-70. PubMed ID: 22986230
[TBL] [Abstract][Full Text] [Related]
31. Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo.
Ichihara E; Ohashi K; Takigawa N; Osawa M; Ogino A; Tanimoto M; Kiura K
Cancer Res; 2009 Jun; 69(12):5091-8. PubMed ID: 19491268
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models.
Sahovaler A; Valic MS; Townson JL; Chan HHL; Zheng M; Tzelnick S; Mondello T; Pener-Tessler A; Eu D; El-Sayes A; Ding L; Chen J; Douglas CM; Weersink R; Muhanna N; Zheng G; Irish JC
Cancer Res Commun; 2024 Mar; 4(3):796-810. PubMed ID: 38421899
[TBL] [Abstract][Full Text] [Related]
33. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
34. pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
Paul S; Heng PW; Chan LW
J Pharm Pharmacol; 2016 Apr; 68(4):439-49. PubMed ID: 26946047
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade.
Wu W; Onn A; Isobe T; Itasaka S; Langley RR; Shitani T; Shibuya K; Komaki R; Ryan AJ; Fidler IJ; Herbst RS; O'Reilly MS
Mol Cancer Ther; 2007 Feb; 6(2):471-83. PubMed ID: 17308046
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts.
Wachsberger PR; Lawrence YR; Liu Y; Daroczi B; Xu X; Dicker AP
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):483-91. PubMed ID: 21095630
[TBL] [Abstract][Full Text] [Related]
37. Nimotuzumab shows an additive effect to inhibit cell growth of ALA-PDT treated oral cancer cells.
He X; Hu N; Yang S; Yang Z; Hu L; Wang X; Wen N
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102817. PubMed ID: 35331955
[TBL] [Abstract][Full Text] [Related]
38. Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma.
Kato T; Jin CS; Lee D; Ujiie H; Fujino K; Hu HP; Wada H; Wu L; Chen J; Weersink RA; Kanno H; Hatanaka Y; Hatanaka KC; Kaga K; Matsui Y; Matsuno Y; De Perrot M; Wilson BC; Zheng G; Yasufuku K
Int J Oncol; 2018 Nov; 53(5):2034-2046. PubMed ID: 30226590
[TBL] [Abstract][Full Text] [Related]
39. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
Yawata K; Osada S; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K
Anticancer Res; 2016 Oct; 36(10):5215-5226. PubMed ID: 27798882
[TBL] [Abstract][Full Text] [Related]
40. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.
Nowsheen S; Bonner JA; Yang ES
Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
